2026 Methods Summit

Valuing Innovation: Measuring What Matters

Moving Beyond Cost-Effectiveness to the Full Spectrum of Patient-Centered Value

March 25, 2026 - Washington, DC

The 2026 7th Annual Methods Summit will convene leaders in value research, policy, and patient advocacy to examine how value assessment can better reflect the full spectrum of what matters to patients. Grounded in the Center’s principles of methodological rigor, transparency, equity, and patient-centeredness, the Summit will move beyond traditional cost-effectiveness approaches to explore more inclusive and relevant methods for defining and measuring value.

Through focused sessions and collaborative discussion, participants will assess progress and gaps in incorporating patient-centered value elements and explore what is ready, emerging, and next in the field, generating insights to inform a forthcoming methods brief and contributing to the national conversation on value-based decision-making.

Agenda

Wednesday, March 25, 2026

The Summit begins with a welcome, followed by a fireside chat with keynote speaker, Laura Pizzi. Discussion will center around the evolution of value definitions and the potential for new methods beyond traditional cost-effectiveness in value research.

Marc Boutin (Center for Innovation & Value Research, President & CEO)

Laura Pizzi, PharmD, MPH (ISPOR, Chief Science Officer)

This session explores how caregiver impacts, family well-being, and household productivity influence the true value of treatment. Speakers will examine research progress, data limitations, and the importance of integrating family and caregiver impacts on value-based decision-making.

Darcel Jackson, CPXP, LSSGB (Children’s National Hospital, Manager of Patient and Family Centered Care)

Tara Lavelle, PhD (Tufts University School of Medicine, Assistant Professor of Medicine)

Tabassum Majid, PhD, MA (PCORI, Senior Program Officer)

Jason Resendez (National Alliance for Caregiving, President & CEO)

This Session will examine how and whether severity of disease can be more systematically embedded in value assessment. Speakers will discuss new methods in this area that may help to align valuation with societal preferences and advance more equitable decision-making.

Sarah Bermingham, MSc, BSc (Takeda, Global Health Economics Lead)

Suzanne M. Collins (Individual Caregiver Representative)

William Padula, PhD, MSc (University of Southern California, Associate Professor of Pharmaceutical & Health Economics)

Claire Telford, PhD, MSc (Pfizer, HTA, Value & Evidence Methods Innovation Lead)

This session focuses on “scientific spillover,” highlighting the ripple effects of research, innovation, and technological advancement that extend beyond individual treatments. Panelists will explore how breakthroughs such as cell and gene therapy and personalized medicine challenge existing value assessment methods and underscore the importance of capturing their wider societal benefits.

Lisa Feng, DrPH, MPH (Bristol Myers Squibb, Senior Director, US Policy Research & Economics)

Mariah J. Scott, MS, MPH (Rutgers University, Researcher, Advocate, and Epidemiologist)

Priscilla VanderVeer, MA (No Patient Left Behind, Executive Director)

Craig Wakeford, MA (Alexion Pharmaceutical)

The Summit will conclude with a keynote from Dr. Nakela Cook who will reflect on how PCORI’s research portfolio connects to the challenges and opportunities raised throughout the day. Marc Boutin will join Dr. Cook for an interactive conversation about where the field must advance next and how researchers, patients, and decision-makers can work together to ensure patient-centered value research drives real-world impact.

Nakela Cook, MD, MPH (PCORI, Executive Director)

Informal networking and refreshments to close the day.

DETAILS

When:
Wednesday, March 25, 2026
9:00 AM – 5:00 PM EDT

Where:
USC Capital Campus
1771 N Street NW
Washington, DC 20036
(In-Person and Live Stream)

Marc Boutin

Center for Innovation & Value Research

Suzanne Collins

Individual Caregiver Representative

Lisa Feng

Bristol Myers Squibb

Darcel Jackson

Children's National Hospital

Tara Lavelle

Tufts University

William Padula

University of Southern California

Jason Resendez

National Alliance for Caregiving

Mariah Scott

Rutgers University

Priscilla VanderVeer

No Patient Left Behind

Craig Wakeford

Alexion, AstraZeneca Rare Disease